189 related articles for article (PubMed ID: 33404854)
1. Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL.
Terasaki M; Terasaki Y; Wakamatsu K; Kuwahara N; Yoneyama K; Kawase R; Kurose K; Toda E; Endo Y; Kunugi S; Kajimoto Y; Shimizu A
Virchows Arch; 2021 May; 478(5):893-904. PubMed ID: 33404854
[TBL] [Abstract][Full Text] [Related]
2. Uterine leiomyosarcoma with osteoclast-like giant cells associated with high expression of receptor activator of nuclear factor κB ligand.
Terasaki M; Terasaki Y; Yoneyama K; Kuwahara N; Wakamatsu K; Nagahama K; Kunugi S; Takeshita T; Shimizu A
Hum Pathol; 2015 Nov; 46(11):1679-84. PubMed ID: 26315618
[TBL] [Abstract][Full Text] [Related]
3. Histochemical assessment of osteoclast-like giant cells in Rankl
Miyamoto Y; Hasegawa T; Hongo H; Yamamoto T; Haraguchi-Kitakamae M; Abe M; Maruoka H; Ishizu H; Shimizu T; Sasano Y; Udagawa N; Li M; Amizuka N
J Oral Biosci; 2023 Jun; 65(2):175-185. PubMed ID: 37088151
[TBL] [Abstract][Full Text] [Related]
4. Uterine Leiomyosarcoma With Osteoclast-like Giant Cells: Report of 2 Cases and Review of Literature.
Chen Z; Ji J; Yung E; Martin SE; Walia S
Int J Gynecol Pathol; 2024 Mar; 43(2):182-189. PubMed ID: 37406452
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast-like cells in soft tissue leiomyosarcomas.
Gibbons CL; Sun SG; Vlychou M; Kliskey K; Lau YS; Sabokbar A; Athanasou NA
Virchows Arch; 2010 Mar; 456(3):317-23. PubMed ID: 20127110
[TBL] [Abstract][Full Text] [Related]
6. Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL-induced NFAT activation and calcium signaling.
Liu C; Cao Z; Zhang W; Tickner J; Qiu H; Wang C; Chen K; Wang Z; Tan R; Dong S; Xu J
J Cell Physiol; 2018 Nov; 233(11):8971-8983. PubMed ID: 29904917
[TBL] [Abstract][Full Text] [Related]
7. Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.
Enomoto H; Shiojiri S; Hoshi K; Furuichi T; Fukuyama R; Yoshida CA; Kanatani N; Nakamura R; Mizuno A; Zanma A; Yano K; Yasuda H; Higashio K; Takada K; Komori T
J Biol Chem; 2003 Jun; 278(26):23971-7. PubMed ID: 12697767
[TBL] [Abstract][Full Text] [Related]
8. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
Li L; Sapkota M; Gao M; Choi H; Soh Y
Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027
[TBL] [Abstract][Full Text] [Related]
9. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
Rao UN; Finkelstein SD; Jones MW
Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
[TBL] [Abstract][Full Text] [Related]
10. Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages.
Byon CH; Sun Y; Chen J; Yuan K; Mao X; Heath JM; Anderson PG; Tintut Y; Demer LL; Wang D; Chen Y
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1387-96. PubMed ID: 21454810
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid leiomyosarcoma with osteoclast-like giant cells in the rectum.
Terada T; Endo K; Maeta H; Horie S; Ohta T
Arch Pathol Lab Med; 2000 Mar; 124(3):438-40. PubMed ID: 10705403
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1.
Yamashita T; Yao Z; Li F; Zhang Q; Badell IR; Schwarz EM; Takeshita S; Wagner EF; Noda M; Matsuo K; Xing L; Boyce BF
J Biol Chem; 2007 Jun; 282(25):18245-18253. PubMed ID: 17485464
[TBL] [Abstract][Full Text] [Related]
14. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.
Liu B; Yu SF; Li TJ
J Oral Pathol Med; 2003 Jul; 32(6):367-75. PubMed ID: 12787044
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.
Morgan T; Atkins GJ; Trivett MK; Johnson SA; Kansara M; Schlicht SL; Slavin JL; Simmons P; Dickinson I; Powell G; Choong PF; Holloway AJ; Thomas DM
Am J Pathol; 2005 Jul; 167(1):117-28. PubMed ID: 15972958
[TBL] [Abstract][Full Text] [Related]
16. [Leiomyosarcoma with prominent osteoclast-like giant cells: a clinicopathologic analysis of 7 cases and review of literature].
Li Y; Xu XL; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):363-7. PubMed ID: 21914342
[TBL] [Abstract][Full Text] [Related]
17. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
[TBL] [Abstract][Full Text] [Related]
19. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
